
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Researchers have recently introduced a robust multiplatform strategy for extracellular vesicle lipid profiling. This integrated workflow combines high-performance liquid chromatography (HPLC-DAD), Fourier transform infrared spectroscopy (ATR-FTIR), and gas chromatography-mass spectrometry (GC-MS). Consequently, this approach addresses the significant analytical challenge of characterizing the complex lipid components that govern vesicle stability and biological activity.
Extracellular vesicles (EVs) are vital for intercellular communication and serve as promising biomarkers for various diseases. However, their molecular diversity often complicates accurate characterization. By utilizing HPLC-DAD for quantitative phospholipid analysis and GC-MS for fatty acid profiling, the study identifies phosphatidylserine as a conserved lipid signature across species. Furthermore, the inclusion of ATR-FTIR spectroscopy allows researchers to derive structural indicators, such as the protein-to-lipid ratio and acyl chain length. These descriptors are essential for establishing a reproducible identity for EVs derived from different sources.
The ability to accurately define EV lipidomes has profound implications for clinical diagnostics and drug delivery. Specifically, the researchers found that microalgal EVs possess distinctive lipid signatures, reinforcing their potential as sustainable nanobiotechnological platforms. In addition, understanding acyl chain saturation and lateral packing helps scientists predict how these vesicles will behave in biological systems. These findings facilitate the translation of complex molecular data into actionable descriptors for medical research and therapeutic development.
Phosphatidylserine is a negatively charged phospholipid typically found on the outer leaflet of extracellular vesicles. It serves as a conserved biomarker that helps identify EVs across different species and mediates their interaction with recipient cells.
ATR-FTIR spectroscopy provides a rapid, label-free biochemical fingerprint. It allows for the calculation of specific ratios, such as the protein-to-lipid ratio, which helps distinguish between different EV sources and ensures quality control in biomanufacturing.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Branca C et al. Expanding the Analytical Toolbox for Extracellular Vesicle Biochemical Profiling: A Multiplatform Spectroscopic and Chromatographic Strategy. Anal Chem. 2026 Apr 24. doi: 10.1021/acs.analchem.5c07632. PMID: 42032802.
Nix C, et al. Development of complementary analytical methods to characterize extracellular vesicles. Anal Chim Acta. 2024 Nov 15;1329:343171. doi: 10.1016/j.aca.2024.343171.
Skotland T, et al. The lipid composition of extracellular vesicles: applications in diagnostics and therapeutic delivery. Lipids. 2017;52(4):301-315. doi: 10.1007/s11745-017-4234-2.

A new integrated workflow using HPLC, FTIR, and GC-MS provides a comprehensive strategy for profiling extracellular vesicle lipids for diagnostic use....
last month

A study at an Ethiopian teaching hospital revealed a 77.1% rate of inappropriate antibiotic prescribing for acute diarrhea, highlighting a global health con...
Today

A review of how EDCs induce persistent epigenetic alterations during fetal development and puberty, shaping endocrine and metabolic outcomes across life....
Today

A case report highlighting subacute normotensive cardiac tamponade as the primary sign of metastatic lung adenocarcinoma, emphasizing early echocardiography...
Today

A review of herbal and synthetic drugs for arthritis, highlighting emerging trends in personalized medication and biotechnology for improved outcomes....
Today

A process evaluation reveals that guideline disagreement, workflow issues, and patient resistance are key barriers to EHR-based diabetes deprescribing....
Today